Orikami.nl
Dutch MedTech organization focused on applied data science to develop, clinically validate and deploy digital biomarkers and software platforms for personalized remote monitoring and decision support in chronic diseases. Services include digital biomarker R&D, clinical validation and study support, a reusable digital-biomarker platform, and regulatory/quality-system support for medical-device compliance.
Industries
Nr. of Employees
small (1-50)
Orikami.nl
Ridderstraat 29, 6511 TM Nijmegen, The Netherlands
Products
Digital biomarker platform (reusable building blocks)
A software platform containing validated digital biomarkers, development building blocks, datasets and quality/regulatory components to accelerate biomarker and solution development.
Mobile monitoring solution for neurological disorders
A smartphone-based solution combining mobility and cognition biomarkers for remote monitoring and clinician decision support in neurological conditions (demonstrated use in MS and Parkinsonian applications).
Digital biomarker platform (reusable building blocks)
A software platform containing validated digital biomarkers, development building blocks, datasets and quality/regulatory components to accelerate biomarker and solution development.
Mobile monitoring solution for neurological disorders
A smartphone-based solution combining mobility and cognition biomarkers for remote monitoring and clinician decision support in neurological conditions (demonstrated use in MS and Parkinsonian applications).
Services
Consulting to identify clinical needs, design sensors/tests, develop algorithms and build proofs-of-concept for digital biomarkers.
End-to-end support for clinical studies including protocol development, recruitment, follow-up, data management and analysis for validation of digital endpoints.
Provision and customization of a reusable digital-biomarker platform and web/mobile portals to deploy monitoring solutions and connect patients with clinicians.
Support for implementing quality management systems and preparation for medical-device certification and market access.
Consulting to identify clinical needs, design sensors/tests, develop algorithms and build proofs-of-concept for digital biomarkers.
End-to-end support for clinical studies including protocol development, recruitment, follow-up, data management and analysis for validation of digital endpoints.
Provision and customization of a reusable digital-biomarker platform and web/mobile portals to deploy monitoring solutions and connect patients with clinicians.
Support for implementing quality management systems and preparation for medical-device certification and market access.
Expertise Areas
- Digital biomarker development
- Clinical validation and study management
- Mobile and wearable sensor analytics
- Machine learning for healthcare
Key Technologies
- Smartphone sensor data acquisition
- Wearable sensor integration
- Near-infrared spectroscopy (NIRS)
- Mobile electroencephalography (mobile EEG)
News & Updates
Participation in a consortium across textiles, data management and wound care; project awarded funding under EFRO OPZuid.
Completed proof-of-concept workstream to support personalized monitoring for elderly lung cancer patients.
Major update to web portal and mobile app introducing a self-service module for creating projects.
Announcement that the organisation developed digital solutions according to MDR and proceeded with certification of its Quality Management System.
Collaboration between the organisation and a biopharmaceutical company to personalize care for lung cancer patients.
Announcement of new investors to support rollout of the organization's monitoring solutions and accelerate product development.
Participation in a consortium across textiles, data management and wound care; project awarded funding under EFRO OPZuid.
Completed proof-of-concept workstream to support personalized monitoring for elderly lung cancer patients.
Major update to web portal and mobile app introducing a self-service module for creating projects.
Announcement that the organisation developed digital solutions according to MDR and proceeded with certification of its Quality Management System.
Collaboration between the organisation and a biopharmaceutical company to personalize care for lung cancer patients.
Announcement of new investors to support rollout of the organization's monitoring solutions and accelerate product development.